Single nucleotide polymorphisms of the adult intestinal stem cell marker Lgr5 in primary and metastatic colorectal cancer

American Journal of Translational Research

Volumn 4, Issue 3, 2012, Pages 279-290

  Kleist, Britta ^a   Xu, Li ^b   Kersten, Christian ^a   Seel, Violetta ^c   Li, Guojun ^b   Poetsch, Micaela ^c  

^a Southern Hospital Trust   (Norway)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Allelic variation; Colorectal cancer; Lgr5; Metastases; Stem cell like cells

Indexed keywords

PROTEIN; PROTEIN LGR5; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GENETICS; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROGNOSIS; PROTEIN EXPRESSION; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; STEM CELL;

EID: 84865010214     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011; 61: 69-90.
2. Aschele C, Debernardis D, Lonardi S, Bandelloni R, Casazza S, Monfardini S, Gallo L. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracilbased chemotherapy. J Clin Oncol 2004; 22: 3758-3765.
3. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM. Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344.
4. Todaro M, Francipane MG, Medema JP, Stassi G. Colon cancer stem cells: promise of targeted therapy. Gastroenterology 2010; 138: 2151-2162.
5. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
6. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol 2009; 217: 307-317.
7. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ and Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009; 457: 608-612.
8. Vermeulen L, Todaro M, De Sousa Mello F, Sprick MR, Kemper K, Alea MP, Richel DJ, Stassi G and Medema JP. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. PNAS 2008; 105: 13427-13432.
9. Gerger A, Zhang W, Dongyun Y, Bohanes P, Ning Y, Winder T, LaBonte MJ, Wilson PM, Benhaim L, Paez D, El-Khoueiry R, El-Khoueiry A, Kahn M, Lenz H-J. Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res 2011; 17: 6934-6943.
10. Coate L, Cuffe S, Horgan A, Hung RJ, Christiani D, Liu G. Germline genetic variation, cancer outcome, and pharmacogenetics. J Clin Oncol 2010; 28: 4029-4037.
11. Hamilton SR, Aaltonen LA (Eds.) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. IARC Press: Lyon 2000; pp: 110-111.
12. TNM classification of malign tumors / edited by Sobin LH, Gospodarowicz MK and Wittekind Ch-7th ed. 2009; pp 100-105.
13. NCBI database: Available from: http:// www.ncbi.nlm.nih.gov/snp).
14. Lee PH, Shatkay H. F-SNP: computationally predicted functional SNPs for disease association studies. Nucleic Acids Res 2008; 36: D820-824.
15. Lee PH, Shatkay H. An integrative scoring system for ranking SNPs by their potential deleterious effects. Bioinformatics 2009; 25: 1048-1055.
16. Kleist B, Xu L, Li G, Kersten C. Expression of the adult intestinal stem cell marker LGr5 in the metastatic cascade of colorectal cancer. Int J Clin Exp Pathol 2011; 4: 327-335.
17. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 2008; 98: 1389-1397.
18. Cheng I, Caberto CP, Lum-Jones A, Seifried A, Wilkens LR, Schumacher FR, Monroe KR, Lim U, Tiirikainen M, Kolonel LN, Henderson BE, Stram DO, Haiman CA, Le Marchand L. Type 2 diabetes risk variants and colorectal cancer risk: the Multiethnic Cohort and PAGE studies. Gut 2011; 60: 1703-1711.
19. Cairns J. Mutation selection and the natural history of cancer. Nature 1975; 225: 197-200.
20. Talmadge JE and Fidler IJ. AACR Centennial Series: The biology of cancer metastasis: Historical perspective. Cancer Res 2010; 70: 5649-5669.
21. Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y and Mori M. Significance of Lgr5+ve cancer stem cells in the colon and rectum. Ann Surg Oncol 2011; 18: 1166-1174.
22. Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T and Dosaka-Akita H. Expression of Lgr5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res 2011; 31: 263-270.
23. De Sousa E Melo F, Colak S, Buikhuisen J, Koster J, Cameron K, de Jong JH, Tuynman JB, Prasetyanti PR, Fessler E, van den Bergh SP, Rodermond H, Dekker E, van der Loos CM, Pals ST, van de Vijver MJ, Versteeg R, Richel DJ, Vermeulen L, Medema JP. Methylation of cancer-stem-cell-associated Wnt target genes predicts poor prognosis in colorectal cancer patients. Cell Stem Cell 2011; 9: 476-485.
24. Walker F, Zhang H-H, Odorizzi A, Burgess AW. Lgr5 is a negative regulator of tumourigenicity, antagonizes Wnt signaling and regulates cell adhesion in colorectal cancer cell lines. PLoS ONE 2011; 6: e22733.